Insider · CIK 0001410514

Thomas Patrick Kelly

cfoofficer

Files at XENE (Xenon Pharmaceuticals Inc.). First filing Oct 1, 2026, latest Oct 1, 2026.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

1 / 0

$560k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

XENE: Xenon Pharmaceuticals Inc.

XENEOct 9, 2026 · close 36.44

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
75Notable	XENEbuy 2 Xenon Pharmaceuticals Inc.	$560k 15,000 shares	-	+2% from low-48% from high	11 d ago

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Sep 30, 2026	XENE Xenon Pharmaceuticals Inc.	POpen-market purchase Common Shares	+15,000	$37.32	$560k	15,000	11 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.